サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：前立腺肥大症治療市場：製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測
市場調査レポート
商品コード
1290832

前立腺肥大症治療市場：製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測

Benign Prostatic Hyperplasia Treatment Market with COVID-19 Impact Analysis, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 354 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
前立腺肥大症治療市場：製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測
出版日: 2023年05月01日
発行: AnalystView Market Insights
ページ情報: 英文 354 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

前立腺肥大症治療市場規模は2022年に110億540万米ドルとなり、2023年から2030年にかけてCAGR 5.9％で拡大

前立腺肥大症治療市場-市場力学

前立腺肥大症治療市場の成長は、前立腺肥大症の有病率の上昇が主な要因です。

前立腺肥大症のような加齢に伴う疾患の負担を急ぐ世界人口は、世界の健康上の優先事項となっています。前立腺肥大症は、高齢男性によくみられる泌尿器科疾患です。前立腺肥大症の年齢別有病率は、剖検評価から推定すると、人生4年目の10年で8％、人生6年目の10年で50％、人生9年目の10年で80％です。前立腺肥大症の負担は、主に人口増加と高齢化により世界中で増加しています。全体として、前立腺肥大症治療市場の成長は、前立腺肥大症の有病率の上昇と前立腺肥大症に関連する泌尿器科疾患の増加が主な要因です。

前立腺肥大症治療市場-主要インサイト

  • 前立腺肥大症治療産業は、持続可能な成長に対する意識の高まりにより、著しい速度で成長すると予測される
  • 製品タイプ別では、薬物治療が2022年に最大の市場シェアを示すと予測されます。
  • 用途別では、在宅医療が2022年の主要タイプでした。
  • 地域別では、北米が2022年の売上高をリードしています。

前立腺肥大症治療市場-セグメンテーション分析：

世界の前立腺肥大症治療市場は、製品タイプ、用途、技術、地域に基づいて区分されます。

市場は製品タイプに基づいて3つのカテゴリーに分けられる：薬物治療、低侵襲手術、レーザー治療、その他。薬物治療は、症状を緩和し、前立腺肥大症の進行を予防するため、市場を独占しています。

市場は用途によって4つのカテゴリーに分けられる：病院、外来手術センター、専門クリニック、在宅医療、その他です。在宅医療が市場を独占しており、予測期間中もその優位性は維持されると思われます。また、患者は術後数週間は処方箋の服用を続ける必要があります。そのため、同市場では病院での治療よりも在宅医療に重点が置かれています。

前立腺肥大症治療市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。北米は、高齢者人口の増加、利用可能な治療オプションに関する一般市民の意識の高まりにより、前立腺肥大症治療市場の成長を支配すると予想されます。American Community Survey（ACS）Data Users Groupによると、65歳以上のアメリカ人の数は2018年の5,200万人から2060年には9,500万人にほぼ倍増し、総人口に占める65歳以上の年齢層の割合は16%から23%に上昇すると予測されています。前立腺肥大症治療市場は、地域によって異なる市場促進要因やエンドユーザー産業の影響を受けます。前立腺肥大症治療市場の企業は、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカなどの各地域の顧客の特定のニーズを満たすために特化したソリューションを開発しています。

前立腺肥大症治療市場-競合情勢：

企業がリーチを強化し、市場シェアを拡大するために使用する主な手法には、新製品の発売、流通網の開拓、研究開発費、M&Aなどがあります。これらの企業はそれぞれ異なる治療オプションや技術を提供しており、治療法の選択は患者の状態、好み、医療提供者の専門知識などの要因によって異なります。具体的な症例を評価し、最も適切な治療法を推奨できる泌尿器科医やヘルスケア専門家に相談することが極めて重要です。例えば、ボストン・サイエンティフィック・コーポレーションは最近、Celsion Corporationから症候性前立腺肥大症の治療技術を購入したと発表しましたが、これは6月13日に開催された同社の年次総会でCelsion の株主が買収を承認したことを受けたものです。

最近の動き

2022年、革新的な医療技術ソリューションを設計・提供する世界のテクノロジーリーダーであるオリンパスは、低侵襲のiTind法を用いた前立腺肥大症（BPH）の商業的治療をカナダで初めて実施したことを発表しました。

研究の主な特徴

  • 前立腺肥大症治療市場に関するこの調査レポートは、2022年を基準年として、市場規模、CAGR、推定・予測（2023-2030年）を提供しています。
  • この調査レポートは、良性前立腺肥大症治療市場に関する最新動向の洞察を顧客に提供します。
  • 調査レポートは、異なるセグメント/国にわたる潜在的な成長機会を解明し、前立腺肥大症治療市場の魅力的な投資提案マトリクスを説明します。
  • 全体的なレポートでは、新規投資機会、既存企業が直面する課題、良性前立腺肥大症治療市場で持続するための成長要因を特定している
  • COVID-19が前立腺肥大症治療市場規模、予測、CAGR、市場力学に与える影響については、調査対象範囲内で詳細に論じています。COVID後の良性前立腺肥大症治療市場に関する詳細な洞察もカバーします。
  • 本レポートのユーザーに前立腺肥大症治療市場の包括的な見解を提供するために、前立腺肥大症治療市場の競合情勢と主要イノベーター分析も含めています。
  • 本調査では、市場規模、成長率、魅力度に基づいてすべての業界セグメントをベンチマークする成長見通しマッピング分析を網羅しています。
  • 本レポートは、ユーザーが前立腺肥大症治療市場で事業展開する企業の財務情報や戦略的イニシアチブを理解するのに役立つ主要な市場参入企業を特集した詳細な企業プロファイルを提供しています。
  • さらに、本レポートは、世界レベルだけでなく地域レベルで市場に関与する主要参入企業の重要な買収＆合併、提携＆ジョイントベンチャー、新発売、研究開発、地域展開も明らかにしています。
  • 世界の前立腺肥大症治療市場レポートは主に、サプライヤー、投資家、新規参入者、流通業者、金融アナリストなど、この業界の様々な利害関係者を対象としています。

目次

第1章 前立腺肥大症治療市場概要

  • 調査範囲

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 前立腺肥大症治療の主要な市場動向

  • 前立腺肥大症治療市場促進要因
  • 前立腺肥大症治療市場抑制要因
  • 前立腺肥大症治療市場の機会
  • 前立腺肥大症治療市場の今後の動向

第4章 前立腺肥大症治療業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 前立腺肥大症治療市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 前立腺肥大症治療市場情勢

  • 前立腺肥大症治療市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 前立腺肥大症治療市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 薬物治療
    • 低侵襲手術
    • レーザー治療
    • その他

第8章 前立腺肥大症治療市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 病院
    • 外来手術センター
    • 専門クリニック
    • 在宅ヘルスケア
    • その他

第9章 前立腺肥大症治療市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の前立腺肥大症治療の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の前立腺肥大症治療の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の前立腺肥大症治療の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの前立腺肥大症治療の主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの前立腺肥大症治療の主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- 前立腺肥大症治療業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Carrier
    • Daikin Industries, Ltd
    • NIBE GroupViessmann Group
    • Glen Dimplex
    • BDR Thermea Group
    • Midea Group
    • Hitachi, Ltd.
    • Ingersoll Rand Plc.
    • STIEBEL ELTRON GmbH &Co. KG
    • Vaillant Group
    • Robert Bosch GmbH
    • The Danfoss Group

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Benign Prostatic Hyperplasia Treatment Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Benign Prostatic Hyperplasia Treatment Market, by Product Type 2018-2030 (USD Million)
  • TABLE Benign Prostatic Hyperplasia Treatment Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Benign Prostatic Hyperplasia Treatment Market, by Application 2018-2030 (USD Million)
  • TABLE Benign Prostatic Hyperplasia Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Benign Prostatic Hyperplasia Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Benign Prostatic Hyperplasia Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Benign Prostatic Hyperplasia Treatment Market share and leading players, 2022
  • FIGURE Europe Benign Prostatic Hyperplasia Treatment Market share and leading players, 2022
  • FIGURE Asia Pacific Benign Prostatic Hyperplasia Treatment Market share and leading players, 2022
  • FIGURE Latin America Benign Prostatic Hyperplasia Treatment Market share and leading players, 2022
  • FIGURE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Benign Prostatic Hyperplasia Treatment Market share analysis by country, 2022
  • FIGURE Germany Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Benign Prostatic Hyperplasia Treatment Market share analysis by country, 2022
  • FIGURE India Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Benign Prostatic Hyperplasia Treatment Market share analysis by country, 2022
  • FIGURE Brazil Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market share analysis by country, 2022
  • FIGURE Saudi Arabia Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Benign Prostatic Hyperplasia Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1307

REPORT HIGHLIGHT

Benign Prostatic Hyperplasia Treatment Market size was valued at USD 11,005.4 million in 2022, expanding at a CAGR of 5.9% from 2023 to 2030.

Benign prostatic hyperplasia, a noncancerous enlargement of the prostate gland, is the most common benign tumor found in men. Many treatments are available for enlarged prostate. These include medicines, surgery, and procedures that involve smaller, fewer, or no cuts. Furthermore, New BPH treatments are less invasive and damaging to healthy tissue than surgery. In general, most of these treatments are outpatient procedures, which means consumers can go home the same day as the procedure. They're also cheaper, have fewer side effects and allow for a faster recovery.

Benign Prostatic Hyperplasia Treatment Market- Market Dynamics

The growth of the benign prostatic hyperplasia therapeutics market is majorly driven due to the rise in the prevalence of benign prostatic hyperplasia.

The global population urging the burden of age-associated diseases, such as benign prostatic hyperplasia, has become a global health priority. Benign prostatic hyperplasia is a common urological disease among older men. The age-specific prevalence of benign prostatic hyperplasia has been estimated from autopsy evaluations to be 8% in the fourth decade of life, 50% in the sixth decade of life, and 80% in the ninth decade of life. The burden of benign prostatic hyperplasia is rising throughout the world, primarily due to population growth and aging. Overall, the growth of the benign prostatic hyperplasia therapeutics market is majorly driven due to the rise in the prevalence of benign prostatic hyperplasia as well as the rise in urological illnesses linked with benign prostatic hyperplasia.

Benign Prostatic Hyperplasia Treatment Market- Key Insights

  • As per the analysis shared by our research analyst, the global Benign Prostatic Hyperplasia Treatment market is estimated to grow annually at a CAGR of around 5.5.% over the forecast period (2023-2030)
  • The Benign Prostatic Hyperplasia Treatment industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on Product type segmentation, Drug treatment was predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Home healthcare was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Benign Prostatic Hyperplasia Treatment Market- Segmentation Analysis:

The Global Benign Prostatic Hyperplasia Treatment Market is segmented on the basis of Product Type, Application, Technology, and Region.

The market is divided into three categories based on product type: Drug treatment, Minimally Invasive Surgeries, laser therapy, and others. Drug treatment dominates the market due to providing symptom relief and facilitating prevent the progression of BPH.

The market is divided into four categories based on application: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, home healthcare, and Others. Home healthcare dominates the market and is likely to maintain its dominance during the forecast period. Patients should also continue taking their prescriptions for a few weeks after surgery. As a result, in his market, the emphasis is biased toward home healthcare rather than hospital care.

Benign Prostatic Hyperplasia Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Benign Prostatic Hyperplasia Treatment market, due to the increasing geriatric population, and rising awareness among the general public about the available treatment options. According to American Community Survey (ACS) Data Users Group, the number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060, and the 65-and-older age group's share of the total population will rise from 16 percent to 23 percent. The Benign Prostatic Hyperplasia Treatment market is influenced by different market drivers and end-user industries across different regions. Companies in the Benign Prostatic Hyperplasia Treatment market develop specialized solutions to meet the specific needs of customers in each region like Europe, Asia pacific, Latin America, the Middle East & Africa, etc.

Benign Prostatic Hyperplasia Treatment Market- Competitive Landscape:

Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. Each of these companies provides different treatment options and technologies, and the choice of treatment depends on factors such as the patient's condition, preferences, and the expertise of the healthcare provider. It's crucial to consult with a urologist or healthcare professional who can assess specific cases and recommend the most appropriate treatment approach. For example, Boston Scientific Corporation recently announced that it has purchased technology for treating symptomatic benign prostatic hyperplasia from Celsion Corporation, following approval of the acquisition by Celsion stockholders at the company's annual meeting on June 13.

Recent Developments:

In 2022, Olympus, a global technology leader in designing and delivering innovative medical technology solutions, announced nowadays the first commercial treatment of Benign Prostatic Hyperplasia (BPH) in Canada using the minimally invasive iTind procedure.

Key features of the study:

  • This proposed research study on Benign Prostatic Hyperplasia Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Benign Prostatic Hyperplasia Treatment market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Benign Prostatic Hyperplasia Treatment market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Benign Prostatic Hyperplasia Treatment market
  • Impact of COVID-19 on Benign Prostatic Hyperplasia Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Benign Prostatic Hyperplasia Treatment market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Benign Prostatic Hyperplasia Treatment market, we have also included competitive landscape and key innovator analysis for the Benign Prostatic Hyperplasia Treatment market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Benign Prostatic Hyperplasia Treatment market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Benign Prostatic Hyperplasia Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET KEY PLAYERS

  • Boston Scientific Corporation
  • Teleflex Incorporated
  • Endo International plc
  • Urologix, LLC
  • LISA Laser
  • Olympus Corporation
  • Other

GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY PRODUCT TYPE

  • Drug Treatment
  • Alpha-blockers
  • 5-Alpha-reductase Inhibitor (5-ARIs)
  • Phosphodiesterase-5 Enzyme Inhibitor
  • Others
  • Minimally Invasive Surgeries
  • Transurethral Resection of the Prostate (TURP)
  • Transurethral Incision of the Prostate (TUIP)
  • Robotic Surgeries
  • Transurethral Microwave Thermotherapy (TUMT)
  • Prostatic Urethral Lift
  • Others
  • Laser Therapy
  • Others

GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY APPLICATION

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Home healthcare
  • Others

GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Benign Prostatic Hyperplasia Treatment Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Benign Prostatic Hyperplasia Treatment Market Snippet by Product Type
    • 2.1.2. Benign Prostatic Hyperplasia Treatment Market Snippet by Application
    • 2.1.3. Benign Prostatic Hyperplasia Treatment Market Snippet by Country
    • 2.1.4. Benign Prostatic Hyperplasia Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Benign Prostatic Hyperplasia Treatment Key Market Trends

  • 3.1. Benign Prostatic Hyperplasia Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Benign Prostatic Hyperplasia Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Benign Prostatic Hyperplasia Treatment Market Opportunities
  • 3.4. Benign Prostatic Hyperplasia Treatment Market Future Trends

4. Benign Prostatic Hyperplasia Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Benign Prostatic Hyperplasia Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Benign Prostatic Hyperplasia Treatment Market Landscape

  • 6.1. Benign Prostatic Hyperplasia Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Benign Prostatic Hyperplasia Treatment Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Drug Treatment
    • 7.1.3. Minimally Invasive Surgeries
    • 7.1.4. Laser Therapy
    • 7.1.5. Others

8. Benign Prostatic Hyperplasia Treatment Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hospitals
    • 8.1.3. Ambulatory Surgical Centers
    • 8.1.4. Specialty Clinics
    • 8.1.5. Home healthcare
    • 8.1.6. Others

9. Benign Prostatic Hyperplasia Treatment Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Benign Prostatic Hyperplasia Treatment Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Carrier
    • 10.2.2. Daikin Industries, Ltd
    • 10.2.3. NIBE GroupViessmann Group
    • 10.2.4. Glen Dimplex
    • 10.2.5. BDR Thermea Group
    • 10.2.6. Midea Group
    • 10.2.7. Hitachi, Ltd.
    • 10.2.8. Ingersoll Rand Plc.
    • 10.2.9. STIEBEL ELTRON GmbH & Co. KG
    • 10.2.10. Vaillant Group
    • 10.2.11. Robert Bosch GmbH
    • 10.2.12. The Danfoss Group

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us